Colorectal Polyps

Polyp Primer - Tiny Troublemakers

• Polyp: An abnormal tissue growth projecting from the colonic mucous membrane into the lumen.
• Broad Classification:
  • Based on Malignant Potential (Histology):
    • Non-neoplastic: Low/no malignant risk (e.g., hyperplastic, inflammatory, hamartomatous).
    • Neoplastic: Possess malignant potential (e.g., adenomas - tubular, villous, tubulovillous; serrated).
  • Based on Gross Appearance (Morphology):
    • Sessile: Flat, broad-based attachment to the mucosa.
    • Pedunculated: Attached by a stalk or pedicle.

⭐ Most colorectal cancers (CRCs) arise from adenomatous polyps, making their detection and removal crucial.

Adenomas - The Risky Bunch

Adenomas are common neoplastic polyps, considered premalignant lesions. Their malignant potential is influenced by several key factors:

• Polyp size: Risk ↑ significantly if > 1 cm.
• Histology: Villous component implies higher risk.
• Dysplasia: Presence of high-grade dysplasia (HGD) is critical.

⭐ Villous adenomas have the highest malignant potential among adenomas.

Syndromic Polyps - Family Matters

• FAP (Familial Adenomatous Polyposis):
  • APC gene mutation. >100 adenomatous polyps (often 1000s).
  • 📌 FAP = "APC gene, Piles of Polyps".

  • ⭐ Familial Adenomatous Polyposis (FAP) has nearly 100% risk of CRC if untreated.

• Gardner's Syndrome: FAP variant (APC). Extracolonic: osteomas, dental anomalies, desmoid tumors, CHRPE.
• Turcot's Syndrome: CNS tumors. FAP (APC) → Medulloblastoma; Lynch (MMR) → Glioblastoma.
• Peutz-Jeghers Syndrome (PJS):
  • STK11 gene. Hamartomatous polyps (GIT, esp. jejunum).
  • Mucocutaneous pigmentation (lips, oral, digits). ↑ risk of GIT, breast, pancreas cancers.
  • 📌 PJs (Pigmentation, Jejunum polyps, STK11).
  • 
• Juvenile Polyposis Syndrome (JPS): SMAD4/BMPR1A genes. Multiple juvenile (hamartomatous) polyps. ↑ CRC risk.
• Lynch Syndrome (HNPCC): MMR gene defects (MLH1, MSH2 etc.). Few polyps, but rapid CRC progression. ↑ risk of endometrial, ovarian, stomach cancers.

Spot & Snip - Finding & Fixing

• Clinical Presentation: Frequently asymptomatic. Key indicators: rectal bleeding, altered bowel habits, iron deficiency anemia.
• Screening (Early Detection):
  • Fecal tests (FOBT, FIT) annually.
  • Colonoscopy: Gold standard. Recommended from age 45-50 for average-risk individuals. Frequency guided by findings.
• Diagnosis: Achieved via colonoscopy with biopsy for definitive histopathological analysis.
• Polypectomy (Removal):
  • Snare polypectomy: Standard for most pedunculated or small sessile polyps.
  • EMR (Endoscopic Mucosal Resection): For larger, flat, or complex polyps. Aim for complete excision.

⭐ Colonoscopy is the gold standard for detection and removal of colorectal polyps.

Aftercare Alley - Surveillance Savvy

Post-polypectomy surveillance prevents CRC. Intervals depend on findings:

• Low-Risk: 1-2 small (<10mm) tubular adenomas, LGD. Scope: 5-10 yrs.
• High-Risk: 3-10 adenomas, OR any adenoma ≥10mm, OR villous, OR HGD. Scope: 3 yrs.

• 10 Adenomas: Scope <3 yrs. Consider polyposis.

⭐ Surveillance intervals are shortened for patients with high-risk adenomas (e.g., ≥3 adenomas, large size, villous features, or high-grade dysplasia).

High‑Yield Points - ⚡ Biggest Takeaways

• Adenomatous polyps: most common, premalignant; surveillance is key.
• Malignant risk: Villous > tubulovillous > tubular adenomas.
• FAP: autosomal dominant, ~100% CRC risk by age 40; prophylactic colectomy needed.
• Lynch syndrome (HNPCC): most common hereditary CRC, MSI-driven, extracolonic cancer risk.
• Serrated polyps (e.g., SSA/P): alternative pathway to CRC, often right-sided.
• Colonoscopy with polypectomy is crucial for CRC prevention.
• High-risk: polyps >1 cm, villous component, high-grade dysplasia.